English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese
| Biosimilars Products | ||
| Name of Product | Strength | USE |
| Filgrastim Prefilled Syringe | 300 mcg/ml | Neutropenia (Oncology) |
| 300 mcg/0.5 ml | ||
| 480 mcg/0.5 ml | ||
| 150 mcg/ml | ||
| 150 mcg/0.5 ml | ||
| 300 mcg/ml Vial | ||
| 480mcg/0.8 ml | ||
| Pegylated rHu Erythropoietin Injection | 50mcg/0.3ml | Treatment of Anemia with CHF |
| 75mcg/0.3ml | ||
| 100mcg/0.3ml | ||
| Teriparatide [rHu PTH (1-34)] Injection for Subcutaneous use only (r-DNA origin) | 750 mcg / 3ml CRG | Postmenopausal women with Osteoporosis |
| Rituximab Conc. Sol. Infusion (Injection) | 100 mg /10 ml & 500 mg / 50 ml | Non-Hodgkin's Lymphoma (NHL) - Oncology |
| Recombinant Follitropin ALFA (rHu FSH Injection) | 300 IU/0.48ml CRG | Anovulation in women |
| 450 IU/0.72ml CRG | ||
| 900 IU/1.44ml CRG | ||
| 75 IU/0.12ml PFS | ||
| 150 IU/0.24ml PFS | ||
| 600 IU/0.96ml CRG | ||
| 1200IU/1.92ml Vial | ||
| 225IU/0.36ml PFS | ||
| 300IU/0.48ml PFS | ||
| Erythropoietin ALFA Injection (PFS) | Erythropoietin Inj. (2000IU/ml) | Anemia in CHF & in Cancer Patients, HIV patients & in blood transfusion |
| Erythropoietin Inj. (4000IU/ml) | ||
| Erythropoietin Inj. (10,000IU/ml) | ||
| Erythropoietin Inj. (3000IU/0.3ml) | ||
| Erythropoietin Inj. (6000 IU/0.6ml) | ||
| Erythropoietin Inj. (4000 IU/0.4ml) | ||
| rHu EPO Alfa Injection 2000 IU/0.5ml | ||
| Erythropoietin Inj. (5000IU/0.5ml) | ||
| rHu EPO Alfa Injection 10000 IU/ml Vial | ||
| rHu EPO Alfa Injection 40000 IU/ml | ||
| Erythropoietin Inj. (2000IU/ml) Vial | ||
| Erythropoietin Inj. (4000IU/ml) Vial | ||
| Erythropoietin Inj. 10,000IU/ml Vial | ||
| rHu EPO Alfa Injection 20000IU/2ml Vial | ||
| Pegfilgrastim Injection Vial / PFS | 6 mg / 0.6 ml & 6 mg / ml | In Treatment of Neutropenia |
| Etanercept Solution for Injection | 0.25 mg / 0.5 ml & 50 mg / 1 ml | Rheumatoid Arthritis |
| Pegylated Recombinant Human Interferon Alfa 2b | 80 mcg/0.5 ml | In Hepatitis B and Hepatitis C |
| 50 mcg/0.5 ml | ||
| 150 mcg/0.5 ml | ||
| 100 mcg/0.5 ml | ||
| 120 mcg/0.5 ml | ||
| Interferon Alfa 2b in PFS | 3 MIU / 1 ml & 5 MIU / 1 ml | For the treatment of Alpha 2b chronic hepatitis B, C & chronic myeloid leukemia patient |
| Ranibizumab Injection | 10 mg / ml vial | Neovascular (wet) age related macular degeneration (AMD) |
405, Harvy Complex, Subhash Chowk, Near A-One School, Gurukul, Ahmedabad, Gujarat, 380052, India
Phone :+917259543975
